Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
11.16
-0.95 (-7.84%)
At close: Nov 10, 2026, 4:00 PM EST
11.20
+0.04 (0.36%)
After-hours: Nov 10, 2026, 6:45 PM EST
Intellia Therapeutics Employees
Intellia Therapeutics had 377 employees as of December 31, 2025. The number of employees decreased by 26 or 6.45% compared to the previous year. That makes Intellia Therapeutics the 22,219th largest employer in the world and 2,886th in the United States.
Employees
377
Change (1Y)
-26
Growth (1Y)
-6.45%
Revenue / Employee
$140,284
Profits / Employee
-$1,130,334
Market Cap
1.57B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 377 | -26 | -6.45% |
| Dec 31, 2024 | 403 | -123 | -23.38% |
| Dec 31, 2023 | 526 | -72 | -12.04% |
| Dec 31, 2022 | 598 | 113 | 23.30% |
| Dec 31, 2021 | 485 | 173 | 55.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Immunocore Holdings | 524 |
| Nurix Therapeutics | 317 |
| uniQure | 221 |
| Precigen | 160 |
| Nanobiotix | 98 |
| SELLAS Life Sciences Group | 13 |
NTLA News
- 11 hours ago - Intellia Therapeutics to Present at Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 1 day ago - Intellia Therapeutics price target raised to $9 from $8 at JPMorgan - TheFly
- 4 days ago - Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 days ago - Intellia Therapeutics price target lowered to $16 from $17 at BofA - TheFly
- 5 days ago - Intellia Therapeutics reports Q3 EPS (91c), consensus (79c) - TheFly
- 5 days ago - Intellia Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 5 days ago - Intellia Therapeutics Earnings release: Q3 2026 - Filings
- 5 days ago - Intellia Therapeutics Quarterly report: Q3 2026 - Filings